Biolife Solutions (BLFS) Asset Writedowns and Impairment (2016 - 2023)

Biolife Solutions (BLFS) reported Asset Writedowns and Impairment of $8.3 million for Q3 2023, up 111.89% quarter-over-quarter from -$69.9 million in Q4 2022.

Biolife Solutions (BLFS) Asset Writedowns and Impairment (2016 - 2023) Analysis & Trends

Biolife Solutions (BLFS) has 4 years of Asset Writedowns and Impairment data on file, last reported at $8.3 million in Q3 2023.

  • Asset Writedowns and Impairment for Q3 2023 came in at $8.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was -$61.6 million (changed N/A YoY), and the FY2023 annual result was $9.7 million, changed N/A from the prior year.
  • Asset Writedowns and Impairment climbed to $8.3 million in Q3 2023 per BLFS's latest filing, from -$69.9 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $69.9 million in Q2 2022 and troughed at -$69.9 million in Q4 2022.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn
10 Biolife Solutions 1.27 Bn 1.19 Bn 17.50 Mn

Historic Data

Download Data
DateValue
Sep 30, 2023 8.31 Mn
Sep 30, 2023 8.31 Mn
Dec 31, 2022 -69.90 Mn
Dec 31, 2022 -69.90 Mn
Jun 30, 2022 69.90 Mn
Jun 30, 2022 69.90 Mn
Dec 31, 2017 336.00
Dec 31, 2017 336.00
Sep 30, 2017 67,664.00
Sep 30, 2017 67,664.00
Jun 30, 2016 86,736.00
Jun 30, 2016 86,736.00